Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study

Jia‐Wei Lv, Ying Sun, Yu‐Pei Chen et al.|Cancer Cell|2024

Cited by 64